文献速递肿瘤 PET/CT

[18F]FDG PET/CT在胸膜间皮瘤中的诊断性能与临床价值:系统综述与荟萃分析

The diagnostic performance and clinical value of [18F]FDG PET/CT in pleural mesothelioma - A systematic review and meta-analysis.
PubMed 文献 · Semin Nucl Med · 2026-06-10

该系统综述与荟萃分析评估了[18F]FDG PET/CT在初治患者中以组织病理学为参考标准诊断胸膜间皮瘤的准确性,并次要评估淋巴结及远处转移诊断、TNM分期影响及PET摄取与体积参数。FDG PET/CT鉴别胸膜间皮瘤与良性胸膜病变的合并敏感度为0.94(95%CI: 0.87-0.97),特异度为0.84(95%CI: 0.73-0.91),研究间存在显著异质性但未检出发表偏倚。

要点

  • FDG PET/CT鉴别胸膜间皮瘤与良性胸膜病变的合并敏感度0.94、特异度0.84。
  • 研究间存在显著异质性,但未检出发表偏倚。
  • 结果支持FDG PET/CT作为胸膜间皮瘤诊断的影像学选择之一。

核心结论

  • FDG PET/CT诊断胸膜间皮瘤具有高敏感度和特异度。
  • 结果为比较FDG PET/CT与其他影像模态提供了更新证据基础。

研究设计与样本

  • 系统综述与荟萃分析,遵循PRISMA指南并预设文献检索策略。
  • 检索词包括「pleura」「pleural」「mesothelioma」「PET」「positron emission tomography」「FDG」「fluorodeoxyglucose」。
  • 两位独立评审者筛选文献、提取数据并评价证据质量。
  • 采用分层模型估计合并诊断准确性参数,Deeks回归检验评估发表偏倚。

主要发现

  • FDG PET/CT鉴别胸膜间皮瘤与良性胸膜病变的合并敏感度为0.94(95%CI: 0.87-0.97)。
  • FDG PET/CT鉴别胸膜间皮瘤与良性胸膜病变的合并特异度为0.84(95%CI: 0.73-0.91)。
  • 研究间存在显著异质性,但未检出发表偏倚。

关键数值与推荐

  • 主要分析以组织病理学为参考标准,评估初治患者中FDG PET/CT诊断胸膜间皮瘤的准确性。
  • 次要分析评估FDG PET/CT或FDG PET/MRI对淋巴结转移和远处转移的诊断准确性及其对TNM分期的影响。
  • 次要分析还评估胸膜间皮瘤的PET摄取参数和体积参数。

临床怎么用

  • 在初治胸膜病变患者中,FDG PET/CT可高敏感度、较高特异度地鉴别胸膜间皮瘤与良性病变。
  • 结果可为FDG PET/CT与增强CT或新型示踪剂PET等模态的诊断性能比较提供参考依据。

局限性

  • 研究间存在显著异质性。
  • 主要目标荟萃分析仅纳入10项研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This systematic review and meta-analysis aims to evaluate the diagnostic accuracy of FDG PET/CT for diagnosing pleural mesothelioma in treatment-naïve patients using histopathology as reference standard. Secondary aims include evaluation of FDG PET/CT or FDG PET/MRI's diagnostic accuracy of lymph node and distant metastases, their impact on TNM-staging, and PET uptake and volumetric parameters in pleural mesothelioma. METHODS: We conducted a systematic review and meta-analysis adhering to 'Preferred Reporting Guidelines for Systematic reviews and Meta-Analyses' (PRISMA) with a predefined literature search. It consisted of the terms: "pleura" or "pleural" or "mesothelioma", "PET" or "positron emission tomography", and "FDG" or "fluorodeoxyglucose". Two independent reviewers systematically screened the literature based on eligibility criteria, extracted data, and evaluated quality of evidence. The meta-analysis was performed using a hierarchical model to estimate pooled diagnostic accuracy parameters. Publication bias was assessed with Deeks' regression test. RESULTS: Forty-one studies were included; the primary aim was evaluated by a meta-analysis which included 10 studies. Thirty-eight studies were included for evaluating secondary aims. The estimated pooled sensitivity and specificity for FDG PET/CT in differentiating pleural mesothelioma from benign pleural lesions were 0.94 (95%CI: 0.87-0.97) and 0.84 (95%CI: 0.73-0.91), respectively. There was substantial study heterogeneity, but no publication bias was detected. CONCLUSION: This study shows high sensitivity and specificity of FDG PET/CT for diagnosing pleural mesothelioma. The results are compatible with previous findings and give an updated evidence base to compare diagnostic performance of FDG PET/CT to other imaging modalities e.g. contrast-enhanced CT or PET with novel tracers.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Thostrup AH, Stubbe NU, Schreiner MP, et al. The diagnostic performance and clinical value of [18F]FDG PET/CT in pleural mesothelioma - A systematic review and meta-analysis. Semin Nucl Med. 2026. PMID: 42270474. doi:10.1053/j.semnuclmed.2026.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。